Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Immucor Accepts $2 Billion Private Equity Buyout, But Open To Richer Offer

This article was originally published in The Gray Sheet

Executive Summary

Blood transfusion testing product maker Immucor will gain added financial resources for future growth following investment firm TPG Capital’s purchase of the company for $1.97 billion, the firm announced July 5.

You may also be interested in...

People In Brief

Accuray, Svelte Medical Systems and Sonoma Orthopedics get new CEOs, and more personnel news from device companies.

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2011

Medical device companies raised a total of $906 million in Q3, while in vitro diagnostic/research developers took in $72 million. The top M&As in each segment were private buyouts of public companies: Kinetic Concepts for $6.3 billion and Immucor for $1.9 billion.

Kinetic Concepts To Go Private Via $6.3 Billion Buyout

Kinetic Concepts’ acceptance of a $6.3 billion private equity buyout deal with a consortium of investors, announced July 13, could mark the opening salvo of a bidding war for the wound care device maker.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts